NSEDisclosure under SEBI Takeover Regulations22 Jun 2026 · 22 Jun 2026, 07:13 pm
Disclosure under SEBI Takeover Regulations
Medicamen Biotech Limited · MEDICAMEQ
✦ AI Summary
Medicamen Biotech Limited has submitted its annual disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This filing, made by the promoter Shivalik Rasayan Limited, covers the year ended March 31, 2026. It is a routine compliance submission to the exchanges.
Analysis Scores
Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
Full Announcement
Medicamen Biotech Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.